These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 17520870)

  • 1. PGE synthase inhibitors as an alternative to COX-2 inhibitors.
    Jachak SM
    Curr Opin Investig Drugs; 2007 May; 8(5):411-5. PubMed ID: 17520870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostanoids and inflammatory pain.
    Chen L; Yang G; Grosser T
    Prostaglandins Other Lipid Mediat; 2013; 104-105():58-66. PubMed ID: 22981510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of microsomal prostaglandin E synthase 1 inhibitors.
    Korotkova M; Jakobsson PJ
    Basic Clin Pharmacol Toxicol; 2014 Jan; 114(1):64-9. PubMed ID: 24138533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Membrane prostaglandin E synthase-1: a novel therapeutic target.
    Samuelsson B; Morgenstern R; Jakobsson PJ
    Pharmacol Rev; 2007 Sep; 59(3):207-24. PubMed ID: 17878511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostaglandin E2 synthesis and secretion: the role of PGE2 synthases.
    Park JY; Pillinger MH; Abramson SB
    Clin Immunol; 2006 Jun; 119(3):229-40. PubMed ID: 16540375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinction of microsomal prostaglandin E synthase-1 (mPGES-1) inhibition from cyclooxygenase-2 inhibition in cells using a novel, selective mPGES-1 inhibitor.
    Mbalaviele G; Pauley AM; Shaffer AF; Zweifel BS; Mathialagan S; Mnich SJ; Nemirovskiy OV; Carter J; Gierse JK; Wang JL; Vazquez ML; Moore WM; Masferrer JL
    Biochem Pharmacol; 2010 May; 79(10):1445-54. PubMed ID: 20067770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostaglandin E(2) synthase inhibition as a therapeutic target.
    Iyer JP; Srivastava PK; Dev R; Dastidar SG; Ray A
    Expert Opin Ther Targets; 2009 Jul; 13(7):849-65. PubMed ID: 19530988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitors of the microsomal prostaglandin E(2) synthase-1 as alternative to non steroidal anti-inflammatory drugs (NSAIDs)--a critical review.
    Koeberle A; Werz O
    Curr Med Chem; 2009; 16(32):4274-96. PubMed ID: 19754418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microsomal prostaglandin E synthase-1 inhibition in cardiovascular inflammatory disease.
    Wang M; Song WL; Cheng Y; Fitzgerald GA
    J Intern Med; 2008 May; 263(5):500-5. PubMed ID: 18410593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microsomal prostaglandin E2 synthase: a safer target than cyclooxygenases?
    Timmers L; Pasterkamp G; de Kleijn DP
    Mol Interv; 2007 Aug; 7(4):195-9, 180. PubMed ID: 17827439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostaglandin E2 is an enhancer of interleukin-1beta-induced expression of membrane-associated prostaglandin E synthase in rheumatoid synovial fibroblasts.
    Kojima F; Naraba H; Sasaki Y; Beppu M; Aoki H; Kawai S
    Arthritis Rheum; 2003 Oct; 48(10):2819-28. PubMed ID: 14558087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microparticles stimulate the synthesis of prostaglandin E(2) via induction of cyclooxygenase 2 and microsomal prostaglandin E synthase 1.
    Jüngel A; Distler O; Schulze-Horsel U; Huber LC; Ha HR; Simmen B; Kalden JR; Pisetsky DS; Gay S; Distler JH
    Arthritis Rheum; 2007 Nov; 56(11):3564-74. PubMed ID: 17968936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineering of a novel hybrid enzyme: an anti-inflammatory drug target with triple catalytic activities directly converting arachidonic acid into the inflammatory prostaglandin E2.
    Ruan KH; Cervantes V; So SP
    Protein Eng Des Sel; 2009 Dec; 22(12):733-40. PubMed ID: 19850676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paracetamol effectively reduces prostaglandin E2 synthesis in brain macrophages by inhibiting enzymatic activity of cyclooxygenase but not phospholipase and prostaglandin E synthase.
    Greco A; Ajmone-Cat MA; Nicolini A; Sciulli MG; Minghetti L
    J Neurosci Res; 2003 Mar; 71(6):844-52. PubMed ID: 12605411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perspective of microsomal prostaglandin E2 synthase-1 as drug target in inflammation-related disorders.
    Koeberle A; Werz O
    Biochem Pharmacol; 2015 Nov; 98(1):1-15. PubMed ID: 26123522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a new mPGES-1 inhibitor in rat models of inflammation.
    Leclerc P; Pawelzik SC; Idborg H; Spahiu L; Larsson C; Stenberg P; Korotkova M; Jakobsson PJ
    Prostaglandins Other Lipid Mediat; 2013; 102-103():1-12. PubMed ID: 23528231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curcumin blocks prostaglandin E2 biosynthesis through direct inhibition of the microsomal prostaglandin E2 synthase-1.
    Koeberle A; Northoff H; Werz O
    Mol Cancer Ther; 2009 Aug; 8(8):2348-55. PubMed ID: 19671757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual acting anti-inflammatory drugs: a reappraisal.
    Bertolini A; Ottani A; Sandrini M
    Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Development of anti-inflammatory drugs targeted against prostaglandin-related molecules].
    Sato T; Nakajima T; Yamano Y
    Nihon Rinsho; 2010 Oct; 68(10):1835-9. PubMed ID: 20954326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of inducible prostaglandin E(2) synthase by 15-deoxy-Delta(12,14)-prostaglandin J(2) and polyunsaturated fatty acids.
    Quraishi O; Mancini JA; Riendeau D
    Biochem Pharmacol; 2002 Mar; 63(6):1183-9. PubMed ID: 11931852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.